Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable bowel syndrome

Authors

Anthony Lembo, Beth Israel Deaconess Medical Center
Mark Pimentel, Cedars-Sinai Medical Center
Satish S. Rao, Regents University
Philip Schoenfeld, University of Michigan-Ann Arbor
Brooks Cash, University of South Alabama
Leonard B. Weinstock, Washington University School of Medicine in St. Louis
Craig Paterson, Salix Pharmaceuticals
Enoch Bortey, Salix Pharmaceuticals
William P. Forbes, Salix Pharmaceuticals

Journal

Gastroenterology

Publication Date

2016

Volume

151

Issue

6

Inclusive Pages

1113-1121

Document Type

Open Access Publication

DOI

10.1053/j.gastro.2016.08.003

Rights and Permissions

Lembo, A., et al (2016) Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome. Gastroenterology, 151(6): 1113-1121. http://dx.doi.org/10.1053/j.gastro.2016.08.003 © 2016 by the AGA Institute. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 0016-5085 http://dx.doi.org/10.1053/j.gastro.2016.08.003

Recommended Citation

Lembo, Anthony; Pimentel, Mark; Rao, Satish S.; Schoenfeld, Philip; Cash, Brooks; Weinstock, Leonard B.; Paterson, Craig; Bortey, Enoch; and Forbes, William P., "Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable bowel syndrome." Gastroenterology. 151, 6. 1113-1121. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/5405